ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and Technology Company, today announced it has signed an agreement with Public Health England (PHE) to manufacture and supply bacterial and fungal NCTC/NCPF Certified Reference Materials (CRM) in LENTICULE® disc format worldwide for use as controls in food, water, environmental and clinical testing microbiology […]
OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing precision medicine through advanced diagnostic tests and clinical and research services, today announced the addition of distributors in China and Japan for its ICEme™ Mutation Enrichment Kits for genomics research. The recently-launched kits use Transgenomic’s Multiplexed ICE COLD-PCR™ (MX-ICP) technology and are designed […]
Darmstadt, Germany – Merck, a leading company for innovative, topquality high-tech products in healthcare, life science and performance materials, successfully placed euro bonds today via its subsidiary Merck Financial Services GmbH. This serves the financing of the proposed acquisition of the U.S. life science company Sigma-Aldrich. In total, three tranches were placed: a floating rate […]
SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) today announced it is collaborating with Dr. Steven Gross, a faculty member in the Department of Pharmacology at Weill Cornell Medical College, in New York, N.Y., to advance research in amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease. Agilent will provide the latest mass spectrometry […]
SOUTH EASTON, Mass — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale of broadly enabling pressure cycling technology (“PCT”)-based sample preparation solutions to the worldwide life sciences industry, today announced it has entered into a two-year collaboration with the Institute of Bioinformatics (“IOB”) in Bangalore, India. The […]
Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed a non- exclusive distribution agreement for the commercialization of SYGNIS’ proprietary product portfolio in Australia with GeneWorks Pty Ltd. Under the terms of the agreement, SYGNIS has granted GeneWorks the rights to promote, market and […]
VANCOUVER, British Columbia — STEMCELL Technologies Inc. has signed a patent license agreement with iPS Academia Japan, Inc. to license and commercialize iPS Academia Japan, Inc.’s patented technologies for induced pluripotent stem cell (iPS cell) research. This agreement will enable STEMCELL Technologies to develop, manufacture, and distribute products that are optimized for cellular reprogramming. This […]
FRANKLIN LAKES, N.J. — BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today announced it has completed the acquisition of Cellular Research, Inc. BD is a global leader in characterizing and isolating single cells for analysis, with more than 30 years of experience in developing […]
Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed a non- exclusive distribution agreement for the commercialization of SYGNIS’ proprietary product portfolio in Australia with GeneWorks Pty Ltd. Under the terms of the agreement, SYGNIS has granted GeneWorks the rights to promote, market and […]
Cambridgeshire, UK — Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical research and industrial markets, has sold its proprietary nucleic acid Heat Elution purification technology1 to Roche. Roche has signed a definitive Asset Purchase Agreement with Lumora for products associated with its proprietary nucleic acid Heat Elution purification technology that is designed […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
